Billeter, Adrian T.

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature

Cancer Immunotherapy and BiomarkersHepatocellular Carcinoma Treatment and Prognosis

Cited by 1,294

Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up: BariScan Study

Nickel, F., Tapking, C., Benner, L., Sollors, J., Billeter, A. T., Kenngott, H. G., Bokhary, L., Schmid, M., von Frankenberg, M., Fischer, L., et al. (2018) · Obesity Surgery

Bariatric Surgery and OutcomesLiver Disease Diagnosis and Treatment

Cited by 100

Jak-TGFβ cross-talk links transient adipose tissue inflammation to beige adipogenesis

Babaei, R., Schuster, M., Meln, I., Lerch, S., Ghandour, R. A., Pisani, D. F., Bayindir-Buchhalter, I., Marx, J., Wu, S., Schoiswohl, G., et al. (2018) · Science Signaling

Adipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Cited by 53

Auto-Aggressive CXCR6(+) CD8 T Cells Cause Liver Immune Pathology in NASH

Dudek, M., Knolle, P., Pfister, D., Heikenwälder, M., Donakonda, S., Laschinger, M., Hartmann, D., Hüser, N., Sebode, M., Filpe, P., et al. (2022) · Zeitschrift für Gastroenterologie

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 18

Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis

Billeter, A. T., Reiners, B., Seide, S. E., Probst, P., Kalkum, E., Rupp, C., & Müller-Stich, B. P. (2022) · Hepatobiliary Surgery and Nutrition

Liver Disease Diagnosis and TreatmentBariatric Surgery and Outcomes

Cited by 12